Filing Details
- Accession Number:
- 0001079973-20-000006
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-01-07 17:11:31
- Reporting Period:
- 2019-12-19
- Accepted Time:
- 2020-01-07 17:11:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1128189 | Protokinetix Inc. | PKTX | Pharmaceutical Preparations (2834) | 943355026 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1516077 | Edward Clarence Smith | 1845 County Road #214 St. Augustine FL 32084 | President & Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-12-19 | 216,666 | $0.12 | 54,899,999 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-12-30 | 21,551 | $0.10 | 13,185,711 | No | 4 | P | Indirect | See footnote |
| Common Stock | Acquisiton | 2019-12-31 | 45,249 | $0.11 | 13,230,960 | No | 4 | P | Indirect | See footnote |
| Common Stock | Acquisiton | 2020-01-03 | 4,200 | $0.10 | 13,235,160 | No | 4 | P | Indirect | See footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Indirect | See footnote |
| No | 4 | P | Indirect | See footnote |
| No | 4 | P | Indirect | See footnote |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Warrant | Acquisiton | 2019-12-19 | 216,666 | $0.00 | 216,666 | $0.12 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 216,666 | 2019-12-19 | 2022-12-18 | No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,850,000 | Indirect | See footnote |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option | $0.11 | 2024-11-17 | 5,000,000 | 5,000,000 | Direct | |
| Common Stock | Stock Option | $0.26 | 2024-07-14 | 5,000,000 | 5,000,000 | Direct | |
| Common Stock | Stock Option | $0.26 | 2024-07-14 | 5,000,000 | 5,000,000 | Direct | |
| Common Stock | Stock Option | $0.09 | 2023-11-08 | 5,000,000 | 5,000,000 | Direct | |
| Common Stock | Stock Option | $0.06 | 2021-08-31 | 5,000,000 | 5,000,000 | Direct | |
| Common Stock | Stock Option | $0.05 | 2020-12-31 | 5,000,000 | 5,000,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2024-11-17 | 5,000,000 | 5,000,000 | Direct |
| 2024-07-14 | 5,000,000 | 5,000,000 | Direct |
| 2024-07-14 | 5,000,000 | 5,000,000 | Direct |
| 2023-11-08 | 5,000,000 | 5,000,000 | Direct |
| 2021-08-31 | 5,000,000 | 5,000,000 | Direct |
| 2020-12-31 | 5,000,000 | 5,000,000 | Direct |
Footnotes
- Acquired pursuant to private placement. This Form 4 corrects the prior Form 4 which incorrectly reported a total of 61,353,833 shares held by Mr. Smith personally. Based on a review of stockholder reports, the corrected number of shares is 54,683,333 before the transactions reported herein.
- Shares held by the Clarence E. Smith Trusts. This Form 4 corrects the prior Form 4 which incorrectly reported a total of 6,467,883 held in trust. Based on a review of brokerage statements and stockholder lists, the corrected total number of shares held by the trusts before the transactions reported herein is 13,164,160.
- This transaction was executed in multiple trades at prices ranging from $0.1 to $0.11. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Shares held by Mr. Smith's retirement account.
- Acquired pursuant to private placement.
- Options issued pursuant to the Company's Amended 2017 Stock Option and Stock Bonus Plan on November 18, 2019. 1,250,000 shares of common stock vest on February 18, 2020; thereafter 1,250,000 shares vest every three months until fully vested on November 18, 2020.
- Options issued pursuant to the Company's Amended 2017 Stock Option and Stock Bonus Plan on July 15, 2019. 1,250,000 shares of common stock vest on October 13, 2019; thereafter 1,250,000 shares vest every three months until fully vested on July 13, 2020.
- Options granted pursuant to Amended 2017 Stock Option and Stock Bonus Plan. On March 31, 2019, 1,250,000 shares vest; thereafter 1,250,000 shares vest each quarter.
- Options granted pursuant to 2017 Stock Option and Stock Bonus Plan. On December 31, 2017, 1,250,000 shares vested; thereafter 1,250,000 shares vested each quarter.
- Options granted pursuant to 2017 Stock Option and Stock Bonus Plan. On March 31, 2017, 1,250,000 shares vested; thereafter 1,250,000 shares vested each quarter.
Billionaire Hedge Funds
